4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LeonaBio, Inc. (LONA) operates in the Biotechnology industry and is headquartered in Bothell, United States with about 19 employees. Its market capitalization is roughly $47 million. In the fiscal year ended 2025-12-31, LONA reported $0M in revenue and ($106M) in net income.
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($102M) | ($101M) | ($126M) | ($104M) | — |
| Net Income | ($106M) | ($97M) | ($118M) | ($96M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($20M) | ($17M) | ($79M) | ($7M) | ($7M) | — |
| Net Income | ($19M) | ($33M) | ($83M) | ($7M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $92M | $59M | $160M | $258M | — |
| Total Liabilities | $64M | $14M | $30M | $23M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LONA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms